GSK beat profit expectations in the fourth quarter, driven by demand for its HIV drugs and Asthma medicine.

Can Baltimore beat heroin with $580M?

GSK ( GSK) shares clocked seven straight sessions of gains, as the stock rose 1.7% at $60.19 on Friday. The multinational healthcare giant gained 16.8% in the preceding six sessions. The stock has ...

AZN gears up for Q4 results as cancer, diabetes and rare disease drugs drive sales expectations ahead of the Feb. 10 earnings ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...

Amgen is running a number of studies of its obesity drug, MariTide.

From detecting heart rhythm problems, to tracking breathing changes Apple devices are among the market leaders in the health ...

Jessie Diggins has become the best-ever American cross-country skier because of what she pushes her body through.

Julissa Hernandez was at work when she saw the news, in 2024, that a young mother, Chianti Means, had jumped to her death at ...

GSK needs drugs in the pipeline to offset some significant patent expiries in the next few years, in particular branded ...

Eli Lilly predicts strong sales growth while rival Novo Nordisk warns of potential declines amid intense price competition in ...

Low-cost air pollution sensors reveal stark disparities in exposure to extreme heat and air pollution in Contra Costa County, ...